Paroxetine Archives - Carey Danis & Lowe

Carey Danis & Lowe Tackle Paxil Birth Defect Claims

By | Paxil, Pharmaceutical litigation, Uncategorized

Published October 12, 2012 by LawsuitInformation.org

Carey Danis & Lowe Tackle Paxil Birth Defect ClaimsPlaintiff’s litigation firm Carey Danis & Lowe is currently accepting new cases regarding Paxil and its link to birth defects when taken by expectant mothers during pregnancy. Paxil lawsuits have cropped up throughout the United States in response to the life altering, and in some cases life threatening, Paxil caused birth defects in newborn babies.

Paxil is an antidepressant drug classified as a selective serotonin re-uptake inhibitor, or an SSRI. It is known generically as Paroxetine. Paxil was developed by GlaxoSmithKline, a British pharmaceutical company.

In July 2012, GlaxoSmithKline pleaded guilty to federal charges claiming, among many other wrongdoings on part of the pharmaceutical giant, that they failed to properly inform the U.S. Food and Drug Administration (FDA), physicians, and patients about data collected in Paxil’s clinical trials. In fact, it has surfaced that GlaxoSmithKline withheld important information about the drug Paxil, information which could have saved lives. GlaxoSmithKline agreed to pay $3 billion in fines to the federal government – the largest health care fraud settlement in U.S. history.

Recently, GlaxoSmithKline made an announcement about its new effort towards transparency. In the announcement made in early October, the British drug maker stated that it would make public the data collected during clinical trials, which was not the case in regards to Paxil’s clinical trials. However, for many patients who used Paxil, such an effort on the part of GlaxoSmithKline is too late.

Pharmaceutical product liability and personal injury attorneys at Carey Danis & Lowe recognize that there are still families out there whose children have suffered from Paxil related birth defects. The lawyers at Carey Danis & Lowe are currently investigating new claims against drug’s maker, GlaxoSmithKline. If your family has been a victim of Paxil birth defects, contact the experienced attorneys at Carey Danis & Lowe for more information about filing a Paxil lawsuit. Call 800-721-2519 for a free legal consultation.

Attorney Jeff Lowe Speaks about Paxil Birth Defects

By | Paxil, Pharmaceutical litigation, Uncategorized

Posted April 27, 2010 

St. Louis, MO: Women who took Paxil during the first trimester of pregnancy and whose children were born with birth defects should consider speaking with an attorney about their options. Jeff Lowe, a partner at Carey Danis & Lowe, says serious birth defects have been linked to the use of Paxil during pregnancy.

Attorney Jeff Lowe Speaks about Paxil Birth Defects “The cases that we’re handling are birth defects that occurred primarily for woman who took Paxil during the first trimester,” Lowe says. “The primary birth defects are Persistent Pulmonary Hypertension of the Newborn (PPHN) and cardiac defects. Those cardiac defects are mainly atrial or septal defects—holes in the heart.”

That does not mean that babies born with other birth defects are excluded from a potential lawsuit. Pregnant women who took any antidepressants from a class of drugs known as selective serotonin reuptake inhibitors (SSRIs, a class that includes Paxil) or serotonin-norepinephrine reuptake inhibitors (SNRIs, a class that includes Effexor) and whose babies were born with birth defects may want to consider speaking to an attorney about their options.

So far the medical literature has made the strongest link between use of certain antidepressants during the first trimester and an increased risk of PPHN or cardiac defects.

“There were studies looking at SSRIs and the early literature didn’t see a connection [between SSRIs and birth defects],” Lowe says. “Then some studies began finding a connection between Paxil and birth defects such as PPHN and cardiac defects. GlaxoSmithKline [Paxil’s manufacturer] had a database they were keeping that was based on their own studies. In 2006, they published their online database, which demonstrated a higher risk in major malformations for infants exposed to Paxil in the first trimester. Additional independent peer reviewed studies confirmed the link.

“Paxil’s warning was changed in 2005 [to include the risk of birth defects]. There was an FDA warning letter issued on December 8, 2005 and a Dear Doctor letter issued in September 2005.”

The good news for potential plaintiffs is that the statute of limitations is not as much of an issue in Paxil birth defect cases as in other situations, because the person most affected by the Paxil is the child. In all states, according to Lowe, “the statute of limitations doesn’t begin to run for a minor until the minor is either 18 to 21 years old, depending on state law, so there isn’t a statute of limitations issue for most children born with birth defects as a result of their mothers taking Paxil.”